Wednesday, May 17, 2006

A few ground rules

The purpose of this new blog is to keep a close eye on the claims being made by Nuclea Biomarkers as to the nature of its products and services.

We have reason to believe that this company and management routinely stretch the boundaries of truth and accuracy beyond breaking point and that in doing so may jeopardize important medical research, waste tax payers' dollars and investors money and damage the careers of those who interact with it into the bargain.

Please focus your posts on facts and personal experience.

3 comments:

Anonymous said...

A Biotechnology executive who
worked with this CEO:

I agree completely with the comments from "concerned biologist said", and can tell you from personal experience that everything I was told turned out to be blatantly false. I lost a great amount of time and money dealing with this guy, and urge my colleagues to stay clear of him. for your sakes, and the sake of your good reputations.

Anonymous said...

I have also had first hand experience with the CEO and the previous entity known as Clinomics. There is not a hint of veracity in anything he says. The tissue bank at Clinomics was of dubious quality at best and there were no actual "board certified" Pathologist reviews but rather arbitrary slide reads and classifications concocted by the CEO himself. Any Pharma, Academic, or Government researcher would be best served to steer clear of this ship of fools and the unqualified charlatan who captains it.

Anonymous said...

It is still going on, but at a greater scale!!